Maribavir Impurity 3
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

176299-71-1Maribavir Impurity 3

● Auf Lager

Katalog-Nr.::VE0028048
CAS-Nr.::176299-71-1
Summenformel::C13H18O9
Molare Masse::318.28 g/mol

Zusätzliche Informationen zu CAS 176299-71-1

Parent drug

Maribavir

IUPAC-Name

(3S,4S,5S)-5-(Acetoxymethyl)tetrahydrofuran-2,3,4-triyl triacetate

Pharmacopeial Synonyms

N/A

Synonyme

N/A

SMILES

CC(OC1[C@@H](OC(C)=O)[C@H]([C@H](COC(C)=O)O1)OC(C)=O)=O

InChI

InChI=1S/C13H18O9/c1-6(14)18-5-10-11(19-7(2)15)12(20-8(3)16)13(22-10)21-9(4)17/h10-13H,5H2,1-4H3/t10-,11-,12-,13?/m0/s1

Beschreibung

Maribavir Impurity 3 (CAS 176299-71-1) is a process-related and/or degradation impurity observed during synthesis and stability of maribavir. It requires comprehensive identification and quantification to establish impurity profiles and control strategies. Analytical characterization typically employs HPLC, LC-MS and NMR to determine retention behavior, exact mass and structural elucidation. Understanding formation pathways helps optimize synthetic steps and formulation conditions to minimize levels. Specifications should be set in line with ICH Q3A and Q3B limits with validated methods for detection at trace levels. Batch release and stability testing include targeted monitoring to ensure safety and product quality.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url